Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Felix Sahm

Showing results (31-40 of 449) with videos related to

Pageof 45
Sort By:
Pediatric Blood & Cancer|February 23, 2022
ALK inhibition as a salvage therapy for a relapsed unclassifiable sarcomatous CNS tumor with EML4/ALK fusion in an infantTill Holsten, Annika Bronsema, Dominik Sturm, et al.
Pediatric Blood & Cancer|December 13, 2017
Response in a child with a BRAF V600E mutated desmoplastic infantile astrocytoma upon retreatment with vemurafenibCornelis M van Tilburg, Florian Selt, Felix Sahm, et al.
Scientific Reports|November 6, 2015
IDH mutation status is associated with a distinct hypoxia/angiogenesis transcriptome signature which is non-invasively predictable with rCBV imaging in human gliomaPhilipp Kickingereder, Felix Sahm, Alexander Radbruch, et al.
NMC Case Report Journal|August 17, 2019
Clinical Significance of Molecular Diagnosis of Pilocytic Astrocytoma: A Case ReportTakahiro Ono, Masataka Takahashi, Junya Hatakeyama, et al.
Neuro-Oncology|May 23, 2017
Diagnostic challenges in meningiomaMartha Nowosielski, Norbert Galldiks, Sarah Iglseder, et al.
Neurosurgical Review|September 19, 2025
Adult pilocytic astrocytomas: challenging the benign paradigm with surgical risks, recurrence dynamics, and molecular insightsDorothea Mitschang, Helena Kleineidam, Felix Hinz, et al.
Neuro-Oncology|December 28, 2023
Cluster-based prognostication in glioblastoma: Unveiling heterogeneity based on diffusion and perfusion similaritiesMartha Foltyn-Dumitru, Tobias Kessler, Felix Sahm, et al.
Plos One|June 1, 2011
The indoleamine-2,3-dioxygenase (IDO) inhibitor 1-methyl-D-tryptophan upregulates IDO1 in human cancer cellsChristiane A Opitz, Ulrike M Litzenburger, Uta Opitz, et al.
Acta Neuropathologica Communications|September 1, 2019
Intraventricular meningiomas frequently harbor NF2 mutations but lack common genetic alterations in TRAF7, AKT1, SMO, KLF4, PIK3CA, and TERTGerhard Jungwirth, Rolf Warta, Christopher Beynon, et al.
Neuropathology and Applied Neurobiology|January 28, 2021
The prognostic significance of clinicopathological features in meningiomas: Microscopic brain invasion can predict patient outcome in otherwise benign meningiomasRouzbeh Banan, Merle Abbetmeier-Basse, Bujung Hong, et al.
Pageof 45

Showing results (31-40 of 449) with videos related to

Sort By:
Pageof 45
Pediatric Blood & Cancer|February 23, 2022
ALK inhibition as a salvage therapy for a relapsed unclassifiable sarcomatous CNS tumor with EML4/ALK fusion in an infantTill Holsten, Annika Bronsema, Dominik Sturm, et al.
Pediatric Blood & Cancer|December 13, 2017
Response in a child with a BRAF V600E mutated desmoplastic infantile astrocytoma upon retreatment with vemurafenibCornelis M van Tilburg, Florian Selt, Felix Sahm, et al.
Scientific Reports|November 6, 2015
IDH mutation status is associated with a distinct hypoxia/angiogenesis transcriptome signature which is non-invasively predictable with rCBV imaging in human gliomaPhilipp Kickingereder, Felix Sahm, Alexander Radbruch, et al.
NMC Case Report Journal|August 17, 2019
Clinical Significance of Molecular Diagnosis of Pilocytic Astrocytoma: A Case ReportTakahiro Ono, Masataka Takahashi, Junya Hatakeyama, et al.
Neuro-Oncology|May 23, 2017
Diagnostic challenges in meningiomaMartha Nowosielski, Norbert Galldiks, Sarah Iglseder, et al.
Neurosurgical Review|September 19, 2025
Adult pilocytic astrocytomas: challenging the benign paradigm with surgical risks, recurrence dynamics, and molecular insightsDorothea Mitschang, Helena Kleineidam, Felix Hinz, et al.
Neuro-Oncology|December 28, 2023
Cluster-based prognostication in glioblastoma: Unveiling heterogeneity based on diffusion and perfusion similaritiesMartha Foltyn-Dumitru, Tobias Kessler, Felix Sahm, et al.
Plos One|June 1, 2011
The indoleamine-2,3-dioxygenase (IDO) inhibitor 1-methyl-D-tryptophan upregulates IDO1 in human cancer cellsChristiane A Opitz, Ulrike M Litzenburger, Uta Opitz, et al.
Acta Neuropathologica Communications|September 1, 2019
Intraventricular meningiomas frequently harbor NF2 mutations but lack common genetic alterations in TRAF7, AKT1, SMO, KLF4, PIK3CA, and TERTGerhard Jungwirth, Rolf Warta, Christopher Beynon, et al.
Neuropathology and Applied Neurobiology|January 28, 2021
The prognostic significance of clinicopathological features in meningiomas: Microscopic brain invasion can predict patient outcome in otherwise benign meningiomasRouzbeh Banan, Merle Abbetmeier-Basse, Bujung Hong, et al.
Pageof 45